# Evaluation of the Attenuation by Aes-103 of Hypoxia Mediated Decrements in Endurance Exercise Performance

> **NCT01871142** · PHASE1,PHASE2 · COMPLETED · sponsor: **Colorado State University** · enrollment: 12 (actual)

## Conditions studied

- Hypoxia

## Interventions

- **DRUG:** Placebo
- **DRUG:** Aes-103
- **DRUG:** Aes-103

## Key facts

- **NCT ID:** NCT01871142
- **Lead sponsor:** Colorado State University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2013-06
- **Final completion:** 2014-06
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2014-10-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01871142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01871142, "Evaluation of the Attenuation by Aes-103 of Hypoxia Mediated Decrements in Endurance Exercise Performance". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01871142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*